Children’s Hospital Los Angeles leads largest ever multi-center study to characterize side effects of a common chemotherapy agent
Scientists at Children’s Hospital Los Angeles develop newer CAR T therapy that promises to be more effective and less toxic for children with neuroblastoma.
Ramon Durazo-Arvizu, PhD, has been named the new faculty director of the Biostatistics and Data Analysis Core of The Saban Research Institute at Children’s Hospital Los Angeles. Dr. Durazo-Arvizu has also been appointed to a USC faculty position as Professor of Research...
Research suggests a potential link between SARS-CoV-2 mutations and disease severity.